The Department of Health and Social Care and the National Assembly of Wales has confirmed that the following products in Part VIIIA of the Drug Tariff have had their reimbursement prices redetermined for November 2023 to reflect an increase in their NHS list price:
|
Product |
Pack Size |
Previous List Price |
New List Price |
Category |
|---|---|---|---|---|
|
Conjugated oestrogens 1.25mg tablets |
84 |
£3.58 |
£52.56 |
Cat C based on Premarin |
|
Conjugated oestrogens 300microgram / Medroxyprogesterone 1.5mg modified-release tablets |
84 |
£6.52 |
£34.13 |
Cat C based on Premique Low Dose |
|
Conjugated oestrogens 300microgram tablets |
84 |
£6.07 |
£24.02 |
Cat C based on Premarin |
|
Conjugated oestrogens 625microgram tablets |
84 |
£4.02 |
£26.87 |
Cat C based on Premarin |
Please note, a change to the reimbursement price will also be applied to the branded prescriptions dispensed in November 2023.